Open Access Article
International Journal of Clinical Research. 2022; 6: (3) ; 171-174 ; DOI: 10.12208/j.ijcr.20220137.
Clinical efficacy of Wenxin Granule in the treatment of senile arrhythmia
稳心颗粒治疗老年病心律失常的临床疗效
作者:
郭伊彬 *
海淀第四十四离职干部休养所 北京
*通讯作者:
郭伊彬,单位:海淀第四十四离职干部休养所 北京;
发布时间: 2022-05-31 总浏览量: 507
PDF 全文下载
引用本文
收录截图(CNKI-Scholar)
万方数据(WANFANG DATA)
摘要
目的 观察稳心颗粒治疗老年病心律失常的临床疗效。方法 选择我所2021.01~2022.01期间接诊的老年病心律失常病患共计28名,回顾统计背景下,“平行对照分组法”平均分设常规组、实验组,每组14名。常规组应用常规治疗法,实验组在常规组基础上增加应用稳心颗粒治疗法,比较两组治疗前后心电图数据、临床治疗效果、治疗前后血液流变学指标。结果 治疗前,两组对比心电图数据、血液流变学指标无比较差异,P>0.05。治疗后,相较常规组,实验组各项心电图数据、血液流变学指标更低,P<0.05。相较常规组,实验组临床治疗效果更高,P<0.05。结论 老年病心律失常者依靠稳心颗粒治疗效果良好,可积极改善不良症状,建议临床应用。
关键词: 老年病;心律失常;稳心颗粒;治疗效果
Abstract
Objective: To observe the clinical efficacy of Wenxin Granule in the treatment of senile arrhythmia. Methods: a total of 28 elderly patients with arrhythmia treated in our hospital from January 2021 to January 2022 were selected. Under the background of retrospective statistics, the "parallel control grouping method" was divided into routine group and experimental group, with 14 patients in each group. The routine group was treated with routine treatment, and the experimental group was treated with Wenxin Granule on the basis of the routine group. The ECG data, clinical treatment effect and hemorheological indexes before and after treatment were compared between the two groups. Results: before treatment, there was no difference in ECG data and hemorheological indexes between the two groups (P > 0.05). After treatment, compared with the routine group, the ECG data and hemorheological indexes in the experimental group were lower (P < 0.05). Compared with the routine group, the clinical therapeutic effect of the experimental group was higher (P < 0.05). Conclusion : the treatment effect of Wenxin Granule for elderly patients with arrhythmia is good, which can actively improve adverse symptoms. It is suggested to be used in clinical practice.
Key words: Senile Diseases; Arrhythmia; Wenxin Granule; Treatment Effect
参考文献 References
[1] 武锋超,蓝庆肃等. 稳心颗粒联合美托洛尔对老年冠心病心律失常患者疗效与安全性的Meta分析[J]. 老年医学研究,2021,2(01):14-21.
[2] 葛文坤,宋春阳. 稳心颗粒联合美托洛尔治疗老年冠心病心律失常患者的临床效果[J]. 临床医学研究与实践, 2021, 6(34):130-132.
[3] 蓝勇. 美托洛尔联合稳心颗粒治疗老年缺血性心律失常(频发室性早搏)临床研究[J]. 家庭中医药,2021, 28 (10): 44-46.
[4] 赵晓迪. 稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J]. 当代医学,2021, 27(26): 116-117.
[5] 谭光长,吴沐基,吴伟攀. 稳心颗粒联合美托洛尔治疗老年冠心病心律失常患者的临床效果及对血液流变学指标的影响[J]. 临床医学研究与实践,2021,6(06):117-119.
引用本文
郭伊彬, 稳心颗粒治疗老年病心律失常的临床疗效[J]. 国际临床研究杂志, 2022; 6: (3) : 171-174.